Microscopic analysis and quality assessment of induced sputum from children with pneumonia

Microscopic analysis and quality assessment of induced sputum from children with pneumonia

Krishna Mohan Gulla, Sushil K. Kabra

Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India

Correspondence to: Sushil K. Kabra. Department of Pediatrics, All India Institute of Medical Sciences, New Delhi 110029, India. Email: skkabra@hotmail.com.

Provenance: This is a Guest Editorial commissioned by the Section Editor Jingyu Guo (State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China).

Comment on: Murdoch DR, Morpeth SC, Hammitt LL, et al. Microscopic Analysis and Quality Assessment of Induced Sputum From Children With Pneumonia in the PERCH Study. Clin Infect Dis 2017;64:S271-9.

Received: 23 August 2017; Accepted: 04 September 2017; Published: 15 September 2017.

doi: 10.21037/jlpm.2017.09.01

Community acquired pneumonia (CAP) in children especially under five years age is more common in developing nations with estimated incidence approximately 0.026 episodes per child year accounting for 95% of all episodes pneumonia in young children worldwide (1). It is leading cause of mortality in children below 5 years of age. Interventions such as empirical antibiotics in children with suspected pneumonia has led to significant reduction in mortality due to pneumonia (2). World Health Organization has suggested identification of pneumonia by rapid respiration and respiratory difficulty and administration of antibiotics in countries with high infant mortality (2). This approach has raised concerns about development of drug resistant organisms. It is observed that majority of children with non-severe pneumonia diagnosed by using WHO criteria had normal X ray films suggesting that they possibly did not have bacterial pneumonia (3). This was supported by randomized controlled trials comparing antibiotics and placebo in non-severe pneumonia diagnosed by WHO criteria; showing no difference in outcome (4,5). These observations suggest that administration of antibiotics may be lifesaving in children with pneumonia caused by bacteria but empirical antibiotics may be responsible for development of drug resistant organisms and their adverse consequences. Therefore it is important to identify causative agents for pneumonia and decide about antibiotics.

Routinely used methods to identify etiological microbiological agents in pneumonia are: Respiratory tract specimens for microscopy and culture, identification of antigens in respiratory specimens and urine, serological studies for certain agents, blood culture, polymerase chain reaction (PCR) (6).

The procedure of respiratory tract specimen collection especially from lower respiratory tract has an enormous influence on microscopy and culture results and interpretation. Commonly used specimen includes throat swabs, nasopharyngeal aspirates, nasopharyngeal washings, sputum, induced sputum, bronchoalveolar lavage, bronchoscopic protected brush sampling and non bronchoscopic lavage. Throat swab cultures are established method for diagnosis of bacterial pharyngitis (7). Nasopharyngeal aspirates and nasopharyngeal washings are used for identification of viral agents and atypical agents (8), Bronchoscopic and non bronchoscopic lavage as well as protected brush sampling are useful specimen but are invasive and need expertise therefore indicated only in selected cases. Sputum examination is commonly used for microbiological investigations in adults with pneumonia. In children sputum sample representing lower airway sample is difficult to obtain as most of time it gets contaminated with throat and airway colonizers. Induced sputum has been used successfully in hospitalized and ambulatory children with tuberculosis (9) and for identification of pneumocystis jiroveci in immunocompromised children with pneumonia (10). There are enough evidence to suggest that induced sputum has good correlation with lower airway microbial agents (bacterial agents i.e., pseudomonas spp., staphylococcus) in children with cystic fibrosis (11). However, there are limited studies on use of induced sputum in children with CAP.

Important steps in obtaining induced sputum includes: induction, collection, assessing its quality, processing for identification of microbial agents using multiple techniques. Induction of sputum and collection are well established as it is being used for diagnosis of tuberculosis in children. Interpretation of sputum for organisms that are not found in oropharynx such as Mycobacterium tuberculosis, atypical agents, PCP etc is easy. However it is difficult for bacterial agents because of high rates of colonization with common bacterial agents that are also responsible for causing pneumonia in children. This is particularly true for sputum (expectorated and induced) which may lead to the incorrect conclusion that upper respiratory tract colonizers are pneumonia pathogens.

Hence, sputum specimens should be checked for quality before processing them for culture. Quality check typically includes calculating the number of squamous epithelial cells (SECs) and polymorphonuclear cells (PMNs) in a Gram stain smear of the specimen.

Murray et al. examined expectorated sputum grossly and microscopically to decide their appropriateness for bacterial culture. The mean number of bacterial species isolated was 2.7 from specimens with <10 SECs per field, 2.4 from transtracheal aspirates and more than 4 from specimens >10 SECs per field. Potential bacterial pathogens were isolated in less than 15% of specimens which had more than 10 SECs per field. The bacterial flora of specimens with fewer than 10 SEC per field was similar to that of transtracheal aspirates (12). Musher et al examined gram stain and culture of sputum specimen from 105 patients with pneumococcal pneumonia proven by blood culture. They defined adequate sputum specimen as ≥10 WBCs for each SEC at magnification of 400×. Performance of culture in those samples yielded correct diagnosis >80% of cases with pneumococcal pneumonia (13). Hence, presence of >25 PMNs and < 10 SECs per low-power field or ≥10 leukocytes for each SEC is regarded as a high quality expectorated sputum specimen in adults (12,13). Specimen which contain relatively high number of SECs and low number of PMNs are regarded as poor quality specimen and represent contamination with upper respiratory tract flora. However, Mycobacterium tuberculosis, Legionella, majority of fungi and viruses do not produce PMNs in sputum and hence, specimen quality can be better measured by assessing the number of SECs per low-power field (14).

Musher et al. showed that microscopic examination of sputum samples before antibiotics administration yielded correct diagnosis in more than 80% of patients with pneumococcal pneumonia (13).One study done on both adults and children to identify respiratory pathogens with TaqMan array card technology concluded that identification of pathogenic bacteria and viruses is better in high quality sputum compared to oropharyngeal or nasopharyngeal swabs (15). Lahti et al. studied 101 children aged 6 months to 15 years with CAP over 15 months. 76 children could produce high quality sputum and possible causative organism could be identified in 90% who produced high quality sputum (16).

Nearly 75% of adults with pneumonia can produce adequate amount and quality of sputum for microbiological diagnosis (17,18). In adults, the sensitivity of sputum examination was reported to be more than 75% for identification of bacterial pathogens. However, prior antibiotic exposure and contamination with oral and oropharyngeal bacteria to be kept in mind (19). Usually it may not be practical to collect sputum from infants and children due to various reasons. Often, children tend to swallow the sputum specimen rather than expectorate it. Compared to adults, high chances of sputum contamination with colonizing bacteria like Streptococcus pneumoniae and Haemophilus influenzae during collection. It is also known that the carriage prevalence of Streptococcus pneumoniae is 6–14% in adults as compared to 57–65% in children aged 5 years, and the carriage prevalence of Haemophilus influenzae is 3% in adults compared with 26% in children aged 5 years (20).

Safety of induced sputum also needs to be considered in children especially those with less than 5 years age. Usually it is done in children with severe or very severe pneumonia requiring hospitalization to identify microorganism. In older children 6–16 yrs age with asthma, induced sputum is shown to be a non-invasive and relatively safe procedure except for few patients experienced moderate bronchospasm, nausea, sore throat, tingling sensation in palms and soles (21,22).Recently two studies done in Kenya and New Caledonia assessed safety of sputum induction among children less than 5 years age who were admitted with severe or very severe pneumonia. Only one child had adverse event in the form of seizures during hypertonic saline nebulisation (23,24). Hence, induced sputum can be performed in children with severe or very severe pneumonia safely.

Murdoch et al. (25) examined 3772 induced sputum specimens from children aged 1 month to 59 months with severe pneumonia who were hospitalized from seven sub African and Asian countries. They intended to get induced sputum prior to initiation of antibiotics and followed standardized protocol at all centres to assure uniformity across the centres. Two thousand six hundred and eight (69%) sputum samples had <10 SECs per low-power field, 2,350 (62%) samples had >25 PMNs per low power field and 1,509 (40%) had both <10 SECs and >25 PMNs per low power field. Samples with SECs <10 per LPF had low quantities of oropharyngeal flora and higher prevalence of potential pneumonia causing pathogens making SECs <10 per LPF as high quality marker of sputum. As the number of SECs increased the prevalence of Hemophilus influenzae, Streptococus pneumoniae, and Moraxella catarrhalis decreased in sputum specimen. However, prevalence of gram-negative bacteria, Staphylococcus aureus increased with number of SECs. The quantity of oropharyngeal flora increased with the presence of greater numbers of SECs, but there was no clear association could be observed with numbers of PMNs. Sputum specimens with SECs <10 per LPF were associated with a lower odds of culturing larger quantities of oropharyngeal flora 0.23 (95% CI, 0.19–0.29) whereas specimens with PMNs >25 per LPF was associated with an increased odds of culturing larger quantities of oropharyngeal flora 1.60 (95% CI, 1.34–1.91) however the effect size was small. This study is one of the few studies that tried to identify etiological agents for pneumonia in children. There are several limitations, including lack of gold standard for comparison, influence of prior antibiotic use on sputum culture and probable discrepancies in the reporting of sputum cultures and Gram stain across different countries where the study took place.

Sputum with <10 SECs and >25 PMNs per LPF have long been regarded as high quality sample (12), however, the prerequisite for large numbers of PMNs has been an issue as some pneumonias are not definitely associated with elevated PMNs (26). On contrary, conditions associated with elevated PMNs in sputum specimen apart from pneumonia like cigarette smoking, pollutants like ozone endotoxins, steroid resistant asthma (27) needs to be kept in mind while assessing sputum quality.

If induced sputum can be used for identification of etiological agents of pneumonia in children, it may be a great step towards rationale use of antibiotics in children. There is need to show reproducibility of results found in study by Murdoch et al. (25) by performing more studies. Equally important is to train paediatric nurses and paediatric physician to induce sputum properly and transport to laboratory. Apart from bacterial culture, there is enormous scope to use molecular technology to identify various etiological agents within few hours.




Conflicts of Interest: The authors have no conflicts of interest to declare.


  1. Rudan I, Tomaskovic L, Boschi-Pinto C, et al. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ 2004;82:895-903. [PubMed]
  2. Sazawal S, Black RE. Pneumonia Case Management Trials Group. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis 2003;3:547-56. [Crossref] [PubMed]
  3. Hazir T. Chest radiography in children aged 2-59 months diagnosed with non-severe pneumonia as defined by World Health Organization: descriptive multicentre study in Pakistan. BMJ 2006;333:629-30. [Crossref] [PubMed]
  4. Agarwal G, Awasthi S, Kabra SK, et al. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. BMJ 2004;328:791-6. [Crossref] [PubMed]
  5. Lodha R, Kabra SK, Pandey RM. Antibiotics for community-acquired pneumonia in children. Cochrane Database Syst Rev 2013;6:CD004874. [PubMed]
  6. Murdoch DR, Jennings LC, Bhat N, Anderson TP. Emerging Advances in Rapid Diagnostics of Respiratory Infections. Infect Dis Clin North Am 2010;24:791-807. [Crossref] [PubMed]
  7. Fox JW, Marcon MJ, Bonsu BK. Diagnosis of Streptococcal Pharyngitis by Detection of Streptococcus pyogenes in Posterior Pharyngeal versus Oral Cavity Specimens. J Clin Microbiol 2006;44:2593-4. [Crossref] [PubMed]
  8. Ginocchio CC, McAdam AJ. Current Best Practices for Respiratory Virus Testing. J Clin Microbiol 2011;49:S44-8. [Crossref]
  9. Zar HJ, Hanslo D, Apolles P, et al. Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet 2005;365:130-4. [Crossref] [PubMed]
  10. Das CK, Mirdha BR, Singh S, et al. Use of Induced Sputum to Determine the Prevalence of Pneumocystis jirovecii in Immunocompromised Children With Pneumonia. J Trop Pediatr 2014;60:216-22. [Crossref] [PubMed]
  11. Kabra SK, Alok A, Kapil A, et al. Can throat swab after physiotherapy replace sputum for identification of microbial pathogens in children with cystic fibrosis? Indian J Pediatr 2004;71:21-3. [Crossref] [PubMed]
  12. Murray PR, Washington JA. Microscopic and baceriologic analysis of expectorated sputum. Mayo Clin Proc 1975;50:339-44. [PubMed]
  13. Musher DM, Montoya R, Wanahita A. Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2004;39:165-9. [Crossref] [PubMed]
  14. Grant LR, Hammitt LL, Murdoch DR, et al. Procedures for Collection of Induced Sputum Specimens From Children. Clin Infect Dis 2012;54:S140-5. [Crossref] [PubMed]
  15. Wolff BJ, Bramley AM, Thurman KA, et al. Improved Detection of Respiratory Pathogens by Use of High-Quality Sputum with TaqMan Array Card Technology. J Clin Microbiol 2016;55:110-21. [Crossref] [PubMed]
  16. Lahti E, Peltola V, Waris M, et al. Induced sputum in the diagnosis of childhood community-acquired pneumonia. Thorax 2009;64:252-7. [Crossref] [PubMed]
  17. Laing R, Slater W, Coles C, et al. Community-acquired pneumonia in Christchurch and Waikato 1999-2000: microbiology and epidemiology. N Z Med J 2001;114:488-92. [PubMed]
  18. Neill AM, Martin IR, Weir R, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996;51:1010-16. [Crossref] [PubMed]
  19. Anevlavis S, Petroglou N, Tzavaras A, et al. A prospective study of the diagnostic utility of sputum Gram stain in pneumonia. J Infect 2009;59:83-9. [Crossref] [PubMed]
  20. Abdullahi O, Nyiro J, Lewa P, et al. The Descriptive Epidemiology of Streptococcus pneumoniae and Haemophilus influenzae Nasopharyngeal Carriage in Children and Adults in Kilifi District, Kenya Pediatr Infect Dis J 2008;27:59-64. [Crossref] [PubMed]
  21. Covar RA, Spahn JD, Martin RJ, et al. Safety and application of induced sputum analysis in childhood asthma. J Allergy Clin Immunol 2004;114:575-82. [Crossref] [PubMed]
  22. Lex C, Payne DNR, Zacharasiewicz A, et al. Sputum induction in children with difficult asthma: Safety, feasibility, and inflammatory cell pattern. Pediatr Pulmonol 2005;39:318-24. [Crossref] [PubMed]
  23. Hammitt LL, Kazungu S, Morpeth SC, et al. A Preliminary Study of Pneumonia Etiology Among Hospitalized Children in Kenya. Clin Infect Dis 2012;54:S190-9. [Crossref] [PubMed]
  24. Mermond S, Zurawski V, D’Ortenzio E, et al. Lower Respiratory Infections Among Hospitalized Children in New Caledonia: A Pilot Study for the Pneumonia Etiology Research for Child Health Project. Clin Infect Dis 2012;54:S180-9. [Crossref] [PubMed]
  25. Murdoch DR, Morpeth SC, Hammitt LL, et al. Microscopic Analysis and Quality Assessment of Induced Sputum From Children With Pneumonia in the PERCH Study. Clin Infect Dis 2017;64:S271-9. [Crossref] [PubMed]
  26. Ingram JG, Plouffe JF. Danger of sputum purulence screens in culture of Legionella species. J Clin Microbiol 1994;32:209-10. [PubMed]
  27. Jayaram L, Parameswaran K, Sears MR, et al. Induced sputum cell counts: their usefulness in clinical practice. Eur Respir J 2000;16:150-8. [Crossref] [PubMed]
doi: 10.21037/jlpm.2017.09.01
Cite this article as: Gulla KM, Kabra SK. Microscopic analysis and quality assessment of induced sputum from children with pneumonia. J Lab Precis Med 2017;2:76.